New Novozymes exec to halt bleeding in struggling growth division

A priority for Novozymes Executive Vice President Tine Sejersgård Fanø is to halt the bleeding which has rendered the growth field of bioethanol a deep disappointment.

Photo: Novozymes/ PR

2017 will be a fateful year for Novozymes, with critical focus on restoring investor confidence in the company.

A large part of the responsibility has landed on the shoulders of Executive Vice President Tine Sejersgård Fanø and her new year's resolution is to deliver.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Further reading

Related articles

Latest News

See all jobs